| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $129.7B | $117.8B | $106.4B | $92.9B | $83.1B | $77.2B | $16.3B | $14.2B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $15.4B | $13.7B | $13.2B | $12.7B | $10.1B | $10.1B | $7.4B | $7.5B |
| Operating Income | $2.7B | $2.6B | $4.0B | $3.8B | $3.1B | $5.0B | $3.2B | $3.1B |
| Net Income | $1.2B | $1.2B | $2.5B | $2.8B | $2.9B | $3.4B | $0.5B | $0.4B |
| EPS (Basic) | $9.87 | $10.01 | $20.09 | $22.20 | $22.79 | $25.47 | $3.87 | $2.60 |
| EPS (Diluted) | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 | $25.31 | $3.84 | $2.58 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $48.9B | $46.5B | $47.1B | $43.1B | $44.4B | $35.0B | $29.1B | $25.4B |
| Current Assets | $32.7B | $29.8B | $30.0B | $26.2B | $24.9B | $23.6B | $19.9B | $16.9B |
| Cash & Equivalents | $4.2B | $2.2B | $4.7B | $5.1B | $3.4B | $4.7B | $4.1B | $2.3B |
| Total Liabilities | $31.2B | $30.0B | $30.7B | $27.7B | $28.3B | $21.2B | $17.0B | $15.3B |
| Current Liabilities | $16.3B | $16.9B | $18.9B | $17.2B | $15.3B | $13.4B | $10.9B | $10.1B |
| Stockholders' Equity | $17.7B | $16.4B | $16.3B | $15.3B | — | $13.7B | $12.0B | $10.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.9B | $3.0B | $4.0B | $4.6B | $2.3B | $5.6B | $5.3B | $2.2B |
| Investing Cash Flow | $2.3B | $-3.0B | $-3.5B | $-1.0B | $-6.6B | $-3.1B | $-1.3B | $-3.1B |
| Capital Expenditures | $0.5B | $0.6B | $1.0B | $1.1B | $1.3B | $1.0B | $0.7B | $0.6B |
| Financing Cash Flow | $-1.2B | $-2.5B | $-0.9B | $-1.9B | $3.0B | $-2.0B | $-2.3B | $-0.8B |